RxSight, Inc. (RXST) Earnings
|
Expand Research on RXST
| Next EPS Date | 11/11/26 | EPS Growth Rate | -625.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +72.3% | Revenue Growth Rate | -10.2% |
| Average % Move 1-Wk after EPS | +1.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/11/26 |
Q326 | N/A | -$0.29 | N/A | N/A | $27.2M | N/A | N/A | N/A | ||
| 8/5/26 | Q226 | -$0.11 | -$0.36 | +$0.25 | $33.74M | $32.21M | N/A | ![]() | ![]() | Details | |
| 5/6/26 | Q126 | -$0.19 | -$0.31 | +$0.12 | $30.9M | $29.75M | N/A | ![]() | ![]() | Details | |
| 2/25/26 | Q425 | -$0.03 | -$0.35 | +$0.32 | $32.6M | $28.11M | N/A | ![]() | ![]() | Details | |
| 11/5/25 | Q325 | -$0.04 | -$0.38 | +$0.34 | $30.3M | $25.28M | = | ![]() | ![]() | Details | |
| 8/7/25 | Q225 | -$0.29 | -$0.19 | -$0.10 | $33.6M | $38.55M | = | ![]() | ![]() | Details | |
| 5/7/25 | Q125 | -$0.03 | -$0.20 | +$0.17 | $37.9M | $39.09M | = | ![]() | ![]() | Details | |
| 2/25/25 | Q424 | $0.03 | -$0.17 | +$0.20 | $40.2M | $40.39M | = | ![]() | ![]() | Details |


